OrthoPediatrics (NASDAQ:KIDS) Sets New 1-Year Low – What’s Next?

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $22.39 and last traded at $22.45, with a volume of 218567 shares trading hands. The stock had previously closed at $23.17.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. JMP Securities reaffirmed a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research note on Friday, September 13th. Truist Financial dropped their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating for the company in a research note on Monday, October 14th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research note on Friday, November 8th.

OrthoPediatrics Stock Performance

The business has a 50 day simple moving average of $25.67 and a two-hundred day simple moving average of $28.67. The firm has a market cap of $557.79 million, a PE ratio of -18.68 and a beta of 1.14. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

Institutional Trading of OrthoPediatrics

A number of hedge funds have recently added to or reduced their stakes in the business. SG Americas Securities LLC bought a new position in OrthoPediatrics in the second quarter worth approximately $110,000. Bank of New York Mellon Corp lifted its stake in shares of OrthoPediatrics by 14.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 68,700 shares of the company’s stock worth $1,976,000 after purchasing an additional 8,887 shares during the last quarter. Commonwealth Equity Services LLC boosted its position in OrthoPediatrics by 0.6% during the second quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock valued at $2,098,000 after purchasing an additional 420 shares in the last quarter. Triodos Investment Management BV grew its stake in OrthoPediatrics by 1.2% in the second quarter. Triodos Investment Management BV now owns 41,500 shares of the company’s stock valued at $1,194,000 after purchasing an additional 500 shares during the last quarter. Finally, Rhumbline Advisers lifted its position in shares of OrthoPediatrics by 19.0% during the second quarter. Rhumbline Advisers now owns 26,613 shares of the company’s stock valued at $765,000 after buying an additional 4,245 shares during the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.